Our expert staff selects the products we cover and rigorously researches and evaluates our top picks. The order in which our top picks are presented may be impacted by partnerships, and we may get ...

India has been traditionally quite strong in the pharma sector, with a low cost of manufacturing (30%–35% lower than in the US and Europe), cost-efficient R&D (about 87% less than in developed markets ...

Novo Nordisk, for its part, is expected to jump from 10th place to sixth this year, according to Evaluate Pharma’s consensus forecasts. Nevertheless, it’s Roche that’s been tipped to stand ...

Explore the detailed Marksans Pharma Ltd balance sheet to understand the company’s financial health and stability. This page provides a clear breakdown of key metrics, including total assets ...

Having solo traveled to over 80 countries across six continents, credit cards enthusiast Kaitlyn Rosati knows a thing or two about travel. Her work has been featured in publications like New York ...

Now Gautam Adani, chairman of the Adani Group, has joined the discussion, stating that work-life balance is achieved when individuals engage in activities they enjoy. He remarked that accepting one’s ...

President-elect Trump’s plan to enact heavy tariffs on certain imports could affect the prices and availability of pharmaceutical drugs in the U.S. Trump has floated 25 percent tariffs on ...

A Reuters analysis of prices for new drugs found that pharmaceutical companies launched new U.S. drugs in 2023 at prices 35% higher than in 2022. The over 250 drug hikes represent an increase from ...

This scenario indicates that 2025 will be a promising year for the pharma sector. A report by Axis Securities last month outlined a positive outlook for the pharmaceutical sector over the next three ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.